Compile Data Set for Download or QSAR
Report error Found 129 Enz. Inhib. hit(s) with all data for entry = 6379
Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125145(US8765744, 94)
Affinity DataIC50: 11nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125155(US8765744, 110)
Affinity DataIC50: 12nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125161(US8765744, 120)
Affinity DataIC50: 13nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125126(US8765744, 70)
Affinity DataIC50: 13nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125109(US8765744, 44)
Affinity DataIC50: 13nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125162(US8765744, 122)
Affinity DataIC50: 16nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125131(US8765744, 78)
Affinity DataIC50: 21nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125116(US8765744, 55)
Affinity DataIC50: 23nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125152(US8765744, 107)
Affinity DataIC50: 24nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125081(US8765744, 79 | US8765744, 11)
Affinity DataIC50: 26nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125158(US8765744, 115)
Affinity DataIC50: 27nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125139(US8765744, 88)
Affinity DataIC50: 27nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125123(US8765744, 64)
Affinity DataIC50: 28nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125136(US8765744, 84)
Affinity DataIC50: 28nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125149(US8765744, 102)
Affinity DataIC50: 28nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125081(US8765744, 79 | US8765744, 11)
Affinity DataIC50: 28nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125113(US8765744, 50)
Affinity DataIC50: 30nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125164(US8765744, 126)
Affinity DataIC50: 32nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125108(US8765744, 42)
Affinity DataIC50: 34nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125102(US8765744, 34)
Affinity DataIC50: 35nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125107(US8765744, 40)
Affinity DataIC50: 35nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125105(US8765744, 37)
Affinity DataIC50: 39nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125085(US8765744, 15)
Affinity DataIC50: 41nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125124(US8765744, 66)
Affinity DataIC50: 41nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125153(US8765744, 108)
Affinity DataIC50: 42nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125160(US8765744, 118)
Affinity DataIC50: 46nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125176(US8765744, 45)
Affinity DataIC50: 49nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125169(US8765744, 4)
Affinity DataIC50: 50nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125154(US8765744, 109)
Affinity DataIC50: 54nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125143(US8765744, 92)
Affinity DataIC50: 55nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125125(US8765744, 68)
Affinity DataIC50: 56nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125130(US8765744, 77)
Affinity DataIC50: 57nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125101(US8765744, 33)
Affinity DataIC50: 65nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125140(US8765744, 89)
Affinity DataIC50: 65nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125201(US8765744, 123)
Affinity DataIC50: 67nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125172(US8765744, 31)
Affinity DataIC50: 69nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125099(US8765744, 30)
Affinity DataIC50: 69nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125103(US8765744, 35)
Affinity DataIC50: 72nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125157(US8765744, 113)
Affinity DataIC50: 73nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125148(US8765744, 100)
Affinity DataIC50: 79nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125151(US8765744, 105)
Affinity DataIC50: 79nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125171(US8765744, 25)
Affinity DataIC50: 80nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125118(US8765744, 58)
Affinity DataIC50: 81nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125114(US8765744, 52)
Affinity DataIC50: 82nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125165(US8765744, 128)
Affinity DataIC50: 86nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125150(US8765744, 104)
Affinity DataIC50: 87nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125106(US8765744, 38)
Affinity DataIC50: 95nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125196(US8765744, 111)
Affinity DataIC50: 100nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125135(US8765744, 82)
Affinity DataIC50: 101nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Target11-beta-hydroxysteroid dehydrogenase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM125146(US8765744, 96)
Affinity DataIC50: 103nMpH: 6.0Assay Description:In vitro inhibition of 11beta -HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internation...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/24/2014
Entry Details
US Patent

Displayed 1 to 50 (of 129 total ) | Next | Last >>
Jump to: